US-Based Berry Street and Healthify Merge to Meet Surging Nutritional Management Demand for GLP-1 Receptor Agonists

Overview of the M&A

US-based nutrition startup Berry Street has announced a merger with India-based digital health company Healthify. This partnership is a strategic move anticipating the growing demand for dietary therapy and specialized nutritional management driven by the recent surge in popularity of GLP-1 receptor agonists (weight management medications).

Business Background of Both Companies

Healthify is a digital health platform operating primarily in the Indian market, offering AI-powered nutrition tracking and personalized coaching to support users in maintaining their health. Meanwhile, Berry Street is a US company with strong expertise in clinical evidence-based nutritional guidance.

Purpose of the Merger

The primary focus of this merger is to build a comprehensive support system for the rapidly growing user base of GLP-1 medications. Patients using GLP-1 require advanced and continuous dietary management to cope with side effects such as muscle mass reduction and specific nutrient deficiencies. By integrating their resources, the two companies aim to combine clinical guidance with the convenience of a digital platform to deliver solutions to a broader user base.

Transaction Details

The financial terms and detailed transaction conditions regarding this acquisition remain undisclosed at this time.